TITLE

The Impact of Steroids Given with Macrolide Therapy on Experimental Mycoplasma pneumoniae Respiratory Infection

AUTHOR(S)
Tagliabue, C.; Salvatore, C. M.; Techasaensiri, C.; Mejias, A.; Torres, J. P.; Katz, K.; Gomez, A. M.; Esposito, S.; Principi, N.; Hardy, R. D.
PUB. DATE
October 2008
SOURCE
Journal of Infectious Diseases;10/15/2008, Vol. 198 Issue 8, p1180
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background. Systemic steroids have been advocated in addition to antimicrobial therapy for severe Mycoplasma pneumoniae pneumonia. We evaluated the efficacy of clarithromycin, dexamethasone, and combination therapy for M. pneumoniae respiratory infection. Methods. Mice infected with M. pneumoniae were treated with clarithromycin, dexamethasone, combined clarithromycin/ dexamethasone, or placebo daily; mice were evaluated at baseline and after 1, 3, and 6 days of therapy. Outcome variables included M. pneumoniae culture, lung histopathologic score (HPS), and bronchoalveolar lavage cytokine, chemokine, and growth factor concentrations. Results. Clarithromycin monotherapy resulted in the greatest reductions in M. pneumoniae concentrations. After 3 days of treatment, combination therapy significantly reduced lung HPS compared with placebo, clarithromycin, and dexamethasone alone, whereas, after 6 days of therapy, clarithromycin alone and combination therapy significantly reduced lung HPS compared with placebo. Concentrations of interleukin (IL)-12 p40, RANTES, macrophage chemotactic protein-1, and cytokine-induced neutrophil chemoattractant were significantly lower in mice treated with clarithromycin alone and/or combination therapy compared with dexamethasone alone and/or placebo; combination therapy resulted in a significantly greater reduction than clarithromycin alone for IL-12 p40 and RANTES. Conclusions. Although monotherapy with clarithromycin had the greatest effect on reducing concentrations of M. pneumoniae, combination therapy had the greatest effect on decreasing levels of cytokines and chemokines as well as pulmonary histologic inflammation.
ACCESSION #
34779958

 

Related Articles

  • The Spread of Mycoplasma pneumoniae Is Polyclonal in Both an Endemic Setting in France and in an Epidemic Setting in Israel. Pereyre, Sabine; Charron, Alain; Hidalgo-Grass, Carlos; Touati, Arabella; Moses, Allon E.; Nir-Paz, Ran; Bébéar, Cécile // PLoS ONE;Jun2012, Vol. 7 Issue 6, p1 

    Mycoplasma pneumoniae infections occur both endemically and epidemically, and macrolide resistance has been spreading for 10 years worldwide. A substantial increased incidence of M. pneumoniae infections has been reported in several countries since 2010. Whether this increased incidence is...

  • Mechanisms of Drug Resistance in Mycoplasma pneumoniae. Bébéar, C. M.; Pereyre, S. // Current Drug Targets - Infectious Disorders;Sep2005, Vol. 5 Issue 3, p263 

    Mycoplasma pneumoniae is a pathogenic mycoplasma responsible for respiratory tract infections in humans, occurring worldwide in children and adults. This review briefly focuses on its antibiotic susceptibility profile and on the development of acquired resistance for this microorganism. The lack...

  • Macrolide-Resistant Mycoplasma pneumoniae (MRMP).  // Clinical Infectious Diseases;8/1/2006, Vol. 43 Issue 3, preceding p271 

    The article discusses the report which states that macrolide-resistant mycoplasma pneumoniae (MRMP) isolates recovered from pediatric patients in Japan are resistant to macrolide antibiotics. A clinical trial was conducted to 11 children with respiratory tract infections dues to MRMP who were...

  • What is the best macrolide for atypical pneumonia?  // Journal of Family Practice;Mar2004, Vol. 53 Issue 3, p229 

    This article argues that erythromycin, clarithromycin, and azithromycin are equally effective in treating pneumonia caused by Mycoplasma pneumoniae or Chlamydophila pneumoniae. Macrolide choice can be based on other considerations-cost, side-effects, and effectiveness against other suspected...

  • Macrolide-resistant Mycoplasma pneumoniae: characteristics of isolates and clinical aspects of community-acquired pneumonia. Morozumi, Miyuki; Takahashi, Takashi; Ubukata, Kimiko // Journal of Infection & Chemotherapy (Springer Science & Business;Apr2010, Vol. 16 Issue 2, p78 

    Mycoplasma pneumoniae is one of the main pathogens causing community-acquired respiratory tract infections in children and adults. Macrolide (ML) antibiotics are recognized generally as first-choice agents for M. pneumoniae infections, and these antibiotics were thought to have excellent...

  • Mycoplasma pneumoniae-associated transverse myelitis with unexpected rapid response to macrolide therapy: a case report. Tezer, Hasan; Kara, Ateş; Haliloğlu, Göknur; Devrim, İlker; Karlı-Oğuz, Kader; Sül, Deniz // Turkish Journal of Pediatrics;Nov/Dec2008, Vol. 50 Issue 6, p585 

    A seven-year-old boy admitted with the complaints of fever, weakness in legs, sensory loss in lower limb, and difficulty in voiding lasting for two weeks. His initial symptoms also included cough and fever. His spinal magnetic resonance imaging scan demonstrated acute transverse myelitis, and...

  • High Prevalence of Macrolide Resistance in Mycoplasma pneumoniae Isolates from Adult and Adolescent Patients with Respiratory Tract Infection in China. Bin Cao; Chun-Jiang Zhao; Yu-Dong Yin; Fei Zhao; Shu-Fan Song; Lu Bai; Jian-Zhong Zhang; Ying-Mei Liu; Yu-Yu Zhang; Hui Wang; Chen Wang // Clinical Infectious Diseases;7/15/2010, Vol. 51 Issue 2, p189 

    The resistance rate of 67 Mycoplasma pneumoniae isolates from 356 ambulatory adult patients with respiratory tract infection was 69% (46 of 67). All 46 macrolide-resistant strains harbored point mutations in the 23S ribosomal RNA gene. Patients infected with macrolide-resistant M. pneumoniae...

  • Macrolide-resistant Mycoplasma pneumoniae: its role in respiratory infection. Principi, Nicola; Esposito, Susanna // Journal of Antimicrobial Chemotherapy (JAC);Mar2013, Vol. 68 Issue 3, p506 

    Although the clinical relevance of antibiotic treatment in influencing the natural course of Mycoplasma pneumoniae-associated respiratory diseases is questioned by some physicians, most experts suggest that antibiotics should be systematically used in patients with M. pneumoniae respiratory...

  • Acute Tonsillopharyngitis Associated with Atypical Bacterial Infection in Children: Natural History and Impact of Macrolide Therapy. Esposito, Susanna; Bosis, Samantha; Begliatti, Enrica; Droghetti, Roberta; Tremolati, Elena; Tagliabue, Claudia; Bellasio, Marta; Blasi, Francesco; Principi, Nicola // Clinical Infectious Diseases;7/15/2006, Vol. 43 Issue 2, p206 

    This study evaluated the natural history of acute tonsillopharyngitis associated with atypical bacterial infections, showing that Mycoplasma pneumoniae and Chlamydia pneumoniae organisms are frequently found in children with acute tonsillopharyngitis. The study also demonstrated, for what we...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics